101 vaccine adverse reactions increased, 9804 total… 1 report of serious suspicion occurred

101 vaccine adverse reactions increased, 9804 total… 1 report of serious suspicion occurred

by

Input 2021.03.23 15:58



On the afternoon of the 15th, the Seoul Metropolitan Government disclosed to the media the preparations for the Seoul Metropolitan Government No. 1 Corona Vaccination Center, which was installed in the auditorium of Seongdong-gu Office. In the vaccination center dispensing room, an official is demonstrating the preparation of subdivisions of the vaccine. /yunhap news

There have been 100 cases in Korea that reported to the health authorities that an adverse reaction was suspected after vaccination against the novel coronavirus infection (Corona 19).

The Central Defense Response Headquarters (Bang Dae-bon) announced that 101 new cases were reported as adverse reactions after vaccination as of 0 o’clock on the 23rd.

One serious case was reported that after receiving the AstraZeneca vaccine, a nervous system reaction such as convulsions appeared. All other 100 cases were mild symptoms such as headache, fever, nausea, and vomiting.

There were no further reports of death. The number of reported deaths to date is a cumulative 16.

Earlier, the Corona 19 Vaccination Response Promotion Team has tentatively concluded that 15 out of 16 patients who completed the cause of death analysis were not related to vaccination. However, for two people who are undergoing autopsy, they will be judged after confirming the autopsy results.

There were no additional reports of suspected cases of’anaphylaxis’, which is a severe systemic allergic reaction. As a result, since the start of vaccination on the 26th of last month, the number of suspected adverse reactions reported accumulated 9804. As of 0 o’clock on this day, it is 1.44% of the domestic cumulative inoculation of 68,1443.

Among them, 9,586 cases were related to AstraZeneca vaccine, accounting for 97.8% of all reports. There were 218 cases (2.2%) related to Pfizer vaccine.

This appears to be due to the number of AstraZeneca vaccinations (62,2437) far more than Pfizer vaccinations (59,063).

The reporting rate of adverse reactions compared to those vaccinated was 1.54% for AstraZeneca vaccine and 0.37% for Pfizer vaccine.

There were 7 cases of suspicion of serious adverse reactions other than mild. Five cases of nervous system reactions, including convulsions, and two hospitalizations in the intensive care unit, are all cases related to the AstraZeneca vaccine.

There were 89 suspected cases of anaphylaxis (80 astraZeneca, 9 Pfizer), of which 84 were anaphylactic reactions and 5 were anaphylactic shock.

In addition, 9692 cases, which account for 98.8% of all reports of adverse reactions, were mild cases such as muscle pain, headache, fever, and nausea, which are common after vaccination.

.Source